CUSA-081

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CUSA-081, covering 2022-04-15 to 2024-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality [Phase 3]